MedTrace Logo

High-Intensity Focused Ultrasound Therapy in Treating Patients With Localized Prostate Cancer

NCT00561262 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2013-08-26

No results posted yet for this study

Summary

RATIONALE: High-intensity focused ultrasound energy may be able to kill tumor cells by heating them without affecting normal tissue.

PURPOSE: This phase II trial is studying how well high-intensity focused ultrasound ablation therapy works in treating patients with localized prostate cancer.

Conditions

Interventions

OTHER

questionnaire administration

PROCEDURE

high-intensity focused ultrasound ablation

PROCEDURE

quality-of-life assessment

Sponsors & Collaborators

  • University College London Hospitals

    lead OTHER

Principal Investigators

  • Mark Emberton, MD, FRCS, MBBS · University College London Hospitals

Study Design

Purpose
TREATMENT

Eligibility

Max Age
79 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-05-31
Primary Completion
2009-10-31
Completion
2011-04-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00561262 on ClinicalTrials.gov